entertainment -WSS

entertainment

author：hotspot 2025-10-01 22:59:02 - browse：75231

A dosage of Wegovy, a drug used for weight loss — Amanda Andrade-Rhoades/AP

U.S. regulators approved a label expansion for Novo Nordisk’s obesity drug Wegovy to tout its benefits for the heart, a move that could boost demand and insurance coverage for the already highly popular treatment.

The new label indicates that Wegovy can be used to reduce the risk of major heart complications — including heart attack, stroke, or cardiovascular-related deaths — for people with overweight or obesity and existing heart disease, Novo said in a statement Friday.

The decision was based on results of a large, five-year trial that showed Wegovy cut the risk of cardiovascular problems by 20% in that population. This is the first time a weight loss treatment has been approved to also help improve heart outcomes, the FDA said.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： H.R. 3 is the wrong path to lower drug costs

WSS

California store owner shot dead in dispute over displaying Pride flag: Police

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Late stage cancers on the rise after pandemic delayed screenings

How the first Native Hawaiian psychiatrist helped diversify medicine

Abortion policy in the spotlight at Republican debate

How the drug

Wikipedia

entertainment

focus

Medicare details structure of new drug price negotiation program

PBMs are inflating the cost of generic drugs. They must be reined in

Trump demands the U.S. pay no more for drugs than other countries … again

Medicare slashes safety net hospital payments by nearly $1 billion

Peter Hotez and the public health issue of online harassment

Group behind ProMed defends move to subscription

Hepatitis C has a cure — but many Americans still lack access to it

How I helped Pfizer think through the ethics of Viagra

Anesthesiologist group: stop taking Ozempic before surgery

Judge partially blocks Texas abortion ban for medical emergencies, fatal diagnoses

hotspot

DeSantis wants to import drugs. Biden’s FDA blasted his plan

Chris Christie meets with Zelenskyy during Ukraine trip

FDA advisory panel to debate high blood pressure devices

FDA advisory panel to debate high blood pressure devices

H.R. 3 is the wrong path to lower drug costs

H.R. 3 is the wrong path to lower drug costs

Wikipedia

focus

hotspot

hotspot